CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30776% above fair value
$6.82+0.17 (+2.56%)
Close on Nov 18, 2026Market cap $341.32MP/E –Yield –
CapsoVision free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
CapsoVision's free cash flow for the twelve months ending Jun 30, 2026 was -$27.89M. For fiscal 2025 it was -$22.95M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.95M | – |
| FY2024 | Dec 31, 2024 | -$20.24M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.40M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.11M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.69M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.68M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.56M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.03M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.40M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.06M | – |
See a number that looks wrong?